Body mass index and altered lipid profile as major risk markers for breast cancer progression: a cross-sectional study of postmenopausal women in Pakistan.
Body mass index (BMI)
Breast carcinoma
Lipid profile
Obesity
Post-menopausal
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
04 Feb 2024
04 Feb 2024
Historique:
received:
26
04
2023
accepted:
25
01
2024
medline:
5
2
2024
pubmed:
5
2
2024
entrez:
4
2
2024
Statut:
epublish
Résumé
In Pakistan, the death rate for post-menopausal women with breast cancer is significant due to late detection and delayed referral to proper facilities. There are a few reports on Pakistan's epidemiology and breast cancer risk factors. There are modifiable and non-modifiable risk factors associated with the development of breast carcinoma; of which body mass index (BMI), central obesity, and lipid profile are considered as major risk markers. This was a cross-sectional analytical study. A total of 384 women constituted the present study sample. Purposive sampling was used to collect 192 confirmed new breast cancer cases throughout the study. By using basic random sampling, an equal number of controls were chosen. Studied parameters included age, fasting blood sugar, cholesterol, triglyceride, serum high-density lipoprotein, cholesterol, serum low-density lipoprotein cholesterol, weight, height, BMI, waist circumference, and waist-to-hip ratio. The inclusion criteria of this study were post-menopausal women (45-65 years) in Pakistan. The confirmation of breast carcinoma was done through histopathology. Breast cancer occurrence was taken as a dependent variable, whereas BMI, central obesity, and lipid profile were taken as independent variables. Studied risk factors (cholesterol, BMI, and central obesity) significantly correlated with breast cancer. Cholesterol has a significantly high positive correlation (0.646) with breast cancer. BMI has a positive significant correlation (0.491) with breast cancer, and central obesity has a low but positive significant correlation (0.266) with breast cancer. Moreover, the binary logistic regression model also showed a significant association between biochemical factors and breast cancer occurrence. Regression analysis depicted a linear relationship between a dependent variable (breast cancer occurrence) and independent variables (central obesity, cholesterol, BMI). Postmenopausal overweight (central obesity), increased BMI and high cholesterol levels are major risk factors for breast cancer. Moreover, high total cholesterol proved to be the most significant risk marker for the occurrence of breast cancer in post-menopausal women of Pakistan.
Sections du résumé
BACKGROUND
BACKGROUND
In Pakistan, the death rate for post-menopausal women with breast cancer is significant due to late detection and delayed referral to proper facilities. There are a few reports on Pakistan's epidemiology and breast cancer risk factors. There are modifiable and non-modifiable risk factors associated with the development of breast carcinoma; of which body mass index (BMI), central obesity, and lipid profile are considered as major risk markers.
METHODS
METHODS
This was a cross-sectional analytical study. A total of 384 women constituted the present study sample. Purposive sampling was used to collect 192 confirmed new breast cancer cases throughout the study. By using basic random sampling, an equal number of controls were chosen. Studied parameters included age, fasting blood sugar, cholesterol, triglyceride, serum high-density lipoprotein, cholesterol, serum low-density lipoprotein cholesterol, weight, height, BMI, waist circumference, and waist-to-hip ratio. The inclusion criteria of this study were post-menopausal women (45-65 years) in Pakistan. The confirmation of breast carcinoma was done through histopathology. Breast cancer occurrence was taken as a dependent variable, whereas BMI, central obesity, and lipid profile were taken as independent variables.
RESULTS
RESULTS
Studied risk factors (cholesterol, BMI, and central obesity) significantly correlated with breast cancer. Cholesterol has a significantly high positive correlation (0.646) with breast cancer. BMI has a positive significant correlation (0.491) with breast cancer, and central obesity has a low but positive significant correlation (0.266) with breast cancer. Moreover, the binary logistic regression model also showed a significant association between biochemical factors and breast cancer occurrence. Regression analysis depicted a linear relationship between a dependent variable (breast cancer occurrence) and independent variables (central obesity, cholesterol, BMI).
CONCLUSION
CONCLUSIONS
Postmenopausal overweight (central obesity), increased BMI and high cholesterol levels are major risk factors for breast cancer. Moreover, high total cholesterol proved to be the most significant risk marker for the occurrence of breast cancer in post-menopausal women of Pakistan.
Identifiants
pubmed: 38311739
doi: 10.1186/s12905-024-02929-z
pii: 10.1186/s12905-024-02929-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90Informations de copyright
© 2024. The Author(s).
Références
Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: global statistics for 2020 and 2040. The Breast. 2022;66:15–23.
doi: 10.1016/j.breast.2022.08.010
pubmed: 36084384
pmcid: 9465273
Tufail M, Wu C. Cancer statistics in Pakistan from 1994 to 2021: data from cancer registry. JCO Clin Cancer Inf, (2023): 7e2200142.
Majeed AI, Ullah A, Jadoon M, Ahmad W, Riazuddin S. Screening, diagnosis and genetic study of breast cancer patients in Pakistan. Pakistan J Med Sci. 2020;36(2):16.
Zaheer S, Shah N, Maqbool SA, Soomro NMJB. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, Pakistan: 2004–2025. 2019, 19:1–9.
Yu Z, Bai X, Zhou R, Ruan G, Guo M, Han W, Jiang S. Yang HJIJoC: differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and global burden of Disease 2019. 2023.
Khan NH, Duan SF, Wu DD, Ji XY. Better reporting and awareness campaigns needed for breast cancer in Pakistani women. Cancer Manage Res. 2021 Mar;2:2125–9.
Sun Y-S, Zhao Z, Yang Z-N, Xu F, Lu H-J, Zhu Z-Y, Shi W, Jiang J, Yao P-P, Zhu H-PJI. Risk factors and preventions of breast cancer. 2017, 13(11):1387.
Dibaba DT, Braithwaite D, Akinyemiju TJC. Metabolic syndrome and the risk of breast cancer and subtypes by race, menopause and BMI. 2018, 10(9):299.
Kolb R, Zhang WJC. Obesity and breast cancer: a case of inflamed adipose tissue. 2020, 12(6):1686.
Rosner B, Eliassen AH, Toriola AT, Chen WY, Hankinson SE, Willett WC, Berkey CS. Colditz GAJIjoc: Weight and weight changes in early adulthood and later breast cancer risk. 2017, 140(9):2003–14.
Zimta A-A, Tigu AB, Muntean M, Cenariu D, Slaby O. Berindan-Neagoe IJIJoMS: molecular links between central obesity and breast cancer. 2019, 20(21):5364.
Crispo A, Grimaldi M, D’Aiuto M, Rinaldo M, Capasso I, Amore A, D’Aiuto G, Giudice A, Ciliberto G, Montella MJTB. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women. 2015, 24(1):86–9.
diFlorio-Alexander RM, Song Q, Dwan D, Austin-Strohbehn JA, Muller KE, Kinlaw WB, MacKenzie TA, Karagas MR. Hassanpour SJBcr, treatment: Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients. 2021, 189(1):257–67.
Andò S, Gelsomino L, Panza S, Giordano C, Bonofiglio D, Barone I, Catalano SJC. Obesity, leptin and breast cancer: epidemiological evidence and proposed mechanisms. 2019, 11(1):62.
Kothari C, Diorio C, Durocher, FJIjoms. The importance of breast adipose tissue in breast cancer. 2020, 21(16):5760.
Sciences NIoEH. : Breast cancer risk and environmental factors. In.; 2012.
Langsted A, Freiberg JJ, Nordestgaard BGJC. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. 2008, 118(20):2047–56.
Pandrangi SL, Chittineedi P, Chikati R, Mosquera JAN, Llaguno SNS, Mohiddin GJ, Lanka S, Chalumuri SS, Maddu NJM. Role of lipoproteins in the pathophysiology of breast cancer. 2022, 12(5):532.
Escala-Garcia M, Morra A, Canisius S, Chang-Claude J, Kar S, Zheng W, Bojesen SE, Easton D, Pharoah PD. Schmidt MKJBm: breast cancer risk factors and their effects on survival: a mendelian randomisation study. 2020, 18:1–10.
Mazzuferi G, Bacchetti T, Islam MO. Ferretti GJLiH, Disease: high density lipoproteins and oxidative stress in breast cancer. 2021, 20(1):1–13.
Cedó L, Reddy ST, Mato E, Blanco-Vaca F. Escolà-Gil JCJJocm: HDL and LDL: potential new players in breast cancer development. 2019, 8(6):853.
Praveena S. A study of lipid profiles in carcinoma breast in comparison with normal controls and benign breast diseases. Rajiv Gandhi University of Health Sciences (India); 2018.
Maran L, Hamid A. Hamid SBSJJol: Lipoproteins as markers for monitoring cancer progression. 2021, 2021.
Muhammad A, Mada SB, Malami I, Forcados GE, Erukainure OL, Sani H, Abubakar IBJB. Pharmacotherapy: postmenopausal osteoporosis and breast cancer: the biochemical links and beneficial effects of functional foods. 2018, 107:571–82.
Abudawood, MJJoRiMSTOJoIUoMS. Diabetes and cancer: a comprehensive review. 2019, 24.
Canchola AJ, Anton-Culver H, Bernstein L, Clarke CA, Henderson K, Ma H, Ursin G, Horn-Ross PLJCC. Control: body size and the risk of postmenopausal breast cancer subtypes in the California teachers Study cohort. 2012, 23:473–85.
His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, Galan P, Latino-Martel P, Blacher J. Touvier MJEjoe: prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. 2014, 29:119–32.
Park YMM, White AJ, Nichols HB, O’Brien KM, Weinberg CR. Sandler DPJIjoc: the association between metabolic health, obesity phenotype and the risk of breast cancer. 2017, 140(12):2657–66.
Mashat RM, Zielinska HA, Holly JM, Perks CMJC. A role for ER-Beta in the effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on breast Cancer progression: involvement of the IGF signalling pathway? 2021, 11(1):94.
Xiang Y, Zhou W, Duan X, Fan Z, Wang S, Liu S, Liu L, Wang F, Yu L, Zhou FJF. Metabolic syndrome, and particularly the hypertriglyceridemic-waist phenotype, increases breast cancer risk, and adiponectin is a potential mechanism: a case–control study in Chinese women. 2020, 10:905.
Tehranifar P, Reynolds D, Fan X, Boden-Albala B, Engmann NJ, Flom JD. Terry MBJAoe: multiple metabolic risk factors and mammographic breast density. 2014, 24(6):479–83.